Cohort of patients with sudden sensorineural hearing loss
Prospective Cohort Study of Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
This study is tracking patients with sudden hearing loss to see how well different treatments help them recover over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 20 Years to 100 Years |
| Sex | All |
| Sponsor | Wonju Severance Christian Hospital Academic / other |
| Locations | 1 site (Wŏnju, Gangwon-do) |
| Trial ID | NCT05474963 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a cohort of patients diagnosed with sudden sensorineural hearing loss (SSNHL) at Wonju Severance Christian Hospital. Patients will be evaluated based on their hearing loss diagnosis confirmed through pure tone audiometry and will be monitored for their recovery status, timing, and degree of recovery. The study will track patients who receive various treatments, including cocktail therapy with or without steroids and other interventions. The goal is to gather data that may help understand the recovery patterns in SSNHL patients.
Who should consider this trial
Good fit: Ideal candidates are adults over 20 years old diagnosed with sudden hearing loss of 30dBHL or more within three days.
Not a fit: Patients with suspected inner ear diseases or those who do not consent to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of treatment efficacy and recovery patterns in patients with sudden sensorineural hearing loss.
How similar studies have performed: While there have been studies on SSNHL, this cohort approach focusing on recovery tracking is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients over 20 years of age * A patient who visited Wonju Severance Christian Hospital, Department of Otolaryngology and was diagnosed with sudden hearing loss as it was confirmed that hearing loss of 30dBHL or more occurred within 3 days at three consecutive frequencies in a pure tone audiometry test. * Those who have fully explained the purpose and content of the study and voluntarily agreed to the written consent Exclusion Criteria: * If the patients do not want to or do not fill out the consent form * If treatment is started for sudden hearing loss, but the possibility of other inner ear diseases including Meniere's disease is suspected due to repeated hearing loss, repeated recovery, dizziness, tinnitus, etc. * Other cases where it is judged difficult to carry out the clinical trial due to the judgment of the person in charge of the above clinical trial
Where this trial is running
Wŏnju, Gangwon-do
- Yonsei University Wonju Severance Christian Hospital — Wŏnju, Gangwon-do, South Korea (Recruiting)
Study contacts
- Study coordinator: Tae Hoon Kong, MD, PhD
- Email: cochlear84@yonsei.ac.kr
- Phone: +821044650635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.